Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2003
10/21/2003US6635461 Encoded by isolated nucleic acid; has glycosyltransferase activity; given amino acid sequence; useful as diagnostic and therapeutic agent for cancer and thymus-related disorders
10/21/2003US6635447 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
10/21/2003US6635288 Pulverizing in solvent; therapy for liver disorders
10/21/2003US6635287 Obtaining an extract from producer cells derived from an organism which is xenogeneic to said target cells and which is capable of entering into a dormant state
10/21/2003US6635274 Solution-based transdermal drug delivery system
10/21/2003US6635273 Methods of treating vascular diseases characterized by nitric oxide insufficiency
10/21/2003US6635252 Antibodies to superoxide dismutase-4
10/21/2003US6635250 Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus
10/21/2003CA2310318C Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
10/21/2003CA2257898C Use of aminothiolester derivatives in pharmaceutics
10/21/2003CA2251790C Methods of regulating skin appearance with vitamin b3 compound
10/21/2003CA2240136C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/21/2003CA2213737C 2-arylbenzazole compounds
10/21/2003CA2208714C Bone mass anabolic composition comprising olpadronate
10/21/2003CA2156825C Inhibition of intimal hyperplasia using antibodies to pdgf receptors
10/21/2003CA2153979C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
10/21/2003CA2141964C Pharmaceutical agents containing diphosphonic acids and salts thereof
10/21/2003CA2117883C Erythromycin derivatives
10/21/2003CA2098020C Anti-viral compounds
10/21/2003CA2017166C Metalloproteinase inhibitor
10/16/2003WO2003085377A2 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003WO2003085137A1 Antisense modulation of liver glycogen phosphorylase expression
10/16/2003WO2003085119A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO FcϜ RECEPTOR IIIa
10/16/2003WO2003085118A1 Process for producing antibody composition
10/16/2003WO2003085110A2 Oligomeric compounds for the modulation hif-1alpha expression
10/16/2003WO2003085106A1 Preventives and/or remedies for cancer
10/16/2003WO2003085089A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003WO2003084975A1 New analogs of nitrobenzylthioinosine
10/16/2003WO2003084966A1 Oxazolidinone derivatives
10/16/2003WO2003084964A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
10/16/2003WO2003084963A1 Non-steroidal progesterone receptor modulators
10/16/2003WO2003084962A1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084961A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
10/16/2003WO2003084956A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
10/16/2003WO2003084955A1 Diazabicyclo alkane derivatives with nk1 antagonistic activity
10/16/2003WO2003084954A1 Tropane derivatives as ccr5 modulators
10/16/2003WO2003084952A1 Benzoxazinone-derived compounds, their preparation und use as medicaments
10/16/2003WO2003084951A1 (3z) -3-(3-hydro-isobenzofuran-1-ylidene)-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
10/16/2003WO2003084950A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists
10/16/2003WO2003084949A1 Pyridinoylpiperidines as 5-ht1f agonists
10/16/2003WO2003084948A1 Nitrogenous heterocyclic compound and medicine thereof
10/16/2003WO2003084941A2 Hydroxamic acid derivatives
10/16/2003WO2003084940A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003WO2003084939A1 Benzoxazinone derivatives, the preparation and use thereof as medicaments
10/16/2003WO2003084928A1 Alpha, omega-dicarboximide derivatives as useful uro-selective α1α adrenoceptor blockers
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003084926A2 Polymeric acyl derivatives of indoles
10/16/2003WO2003084917A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003WO2003084916A2 Compounds that modulate ppar activity and methods for their preparation
10/16/2003WO2003084915A1 Novel thyroid receptor ligands
10/16/2003WO2003084570A1 DRUG CONTAINING ANTIBODY COMPOSITION APPROPRIATE FOR PATIENT SUFFERING FROM FcϜRIIIa POLYMORPHISM
10/16/2003WO2003084569A1 Drug containing antibody composition
10/16/2003WO2003084563A1 Glp-1 agonist and cardiovascular complications
10/16/2003WO2003084560A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
10/16/2003WO2003084555A1 Compositions for inhibiting fibrosis
10/16/2003WO2003084542A1 Neurotrophic factor production accelerator
10/16/2003WO2003084541A1 Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers
10/16/2003WO2003084540A2 Compositions comprising mmp7 modulators for the treatment of chronic pain
10/16/2003WO2003084539A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003WO2003084527A1 Severe sepsis preventive therapeutic agent
10/16/2003WO2003084525A1 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
10/16/2003WO2003084524A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003WO2003084503A2 P38 kinase inhibitors for treating mucus hypersecretion_
10/16/2003WO2003084502A1 Inhalation kit comprisung inhalable powder of tiotropium
10/16/2003WO2003084485A1 Composition for cell proliferation
10/16/2003WO2003084344A2 Method of improving absorption of vitamin e by a pet animal
10/16/2003WO2003084343A2 Method and dietary composition for improving fat digestibility
10/16/2003WO2003084342A2 Method and dietary composition for improving lipid digestibility
10/16/2003WO2003070976A3 Methods for determining the influence of protein binding on antiretroviral activity
10/16/2003WO2003070701A3 Syntheses of quinazolinones
10/16/2003WO2003066030A3 Pharmaceutical tablet
10/16/2003WO2003063792A8 Compositions and methods related to tim-3, a th1-specific cell surface molecule
10/16/2003WO2003061620A3 Peptide-carrying bodies for immune response
10/16/2003WO2003057729A3 Mammal prolactin variants
10/16/2003WO2003054216A3 Antibodies that immunospecifically bind to trail receptors
10/16/2003WO2003051905A3 Taojiks as modifiers of the beta-catenin pathway and methods of use
10/16/2003WO2003051313A3 Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes
10/16/2003WO2003048164A3 Adenosine a2a receptor antagonists
10/16/2003WO2003047504A3 Prevention and treatment of androgen-deprivation induced osteoporosis
10/16/2003WO2003046560B1 Self-assembly molecules
10/16/2003WO2003045952A3 Condensed camptothecins as antitumor agents
10/16/2003WO2003045414A3 Use of laminarin in the treatment of cancer as well as bacterial, viral and fungal infections
10/16/2003WO2003041679A3 Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells
10/16/2003WO2003041660A3 Solubilized topoisomerase poisons
10/16/2003WO2003039478A3 Method and apparatus for the stimulation of hair growth
10/16/2003WO2003039469A3 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1
10/16/2003WO2003033660A3 9136, a human aldehyde dehydrogenase family member and uses therefor
10/16/2003WO2003029434A3 Novel molecules of the hkid-1-related protein family and uses thereof
10/16/2003WO2003029413A3 A novel g protein-coupled receptor, gave 10
10/16/2003WO2003028634A3 Method of treatment using ligand-immunogen conjugates
10/16/2003WO2003022218A3 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
10/16/2003WO2003020241A3 Functional powders for oral delivery
10/16/2003WO2003016472A3 Hybrid interferon/interferon tau proteins, compositions and methods of use
10/16/2003WO2003015494A3 Tocopherol enriched compositions and amelioration of inflammatory symptoms
10/16/2003WO2003011314A3 Use of lhrh-antagonists for the improvement of t-cell mediated immunity
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/16/2003WO2003004702A3 Method for determining chromatin structure
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002100826A3 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs
10/16/2003WO2002100347A3 Prodrugs of gaba analogs, compositions and uses thereof
1 ... 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 ... 1564